Iovance Biotherapeutics (IOVA) News Today $2.38 +0.01 (+0.42%) Closing price 04:00 PM EasternExtended Trading$2.35 -0.03 (-1.47%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IOVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 10 at 2:37 AM | marketbeat.comAmerican Century Companies Inc. Decreases Stake in Iovance Biotherapeutics, Inc. $IOVASeptember 9 at 3:15 AM | marketbeat.comH.C. Wainwright Keeps Buy Rating on Iovance (IOVA) After Health Canada Authorization NewsSeptember 8 at 2:51 AM | insidermonkey.comInvenomic Capital Management LP Invests $18.28 Million in Iovance Biotherapeutics, Inc. $IOVASeptember 7 at 7:12 AM | marketbeat.com683 Capital Management LLC Purchases 983,986 Shares of Iovance Biotherapeutics, Inc. $IOVASeptember 4, 2025 | marketbeat.comIovance Biotherapeutics, Inc. $IOVA Shares Acquired by Palo Alto Investors LPSeptember 4, 2025 | marketbeat.comRafferty Asset Management LLC Sells 132,612 Shares of Iovance Biotherapeutics, Inc. $IOVASeptember 3, 2025 | marketbeat.comLong Focus Capital Management LLC Purchases 4,118,055 Shares of Iovance Biotherapeutics, Inc. $IOVASeptember 1, 2025 | marketbeat.comNuveen LLC Takes Position in Iovance Biotherapeutics, Inc. $IOVAAugust 31, 2025 | marketbeat.comOrion Investment Co Buys 116,098 Shares of Iovance Biotherapeutics, Inc. $IOVAAugust 30, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 141,599 Shares of Iovance Biotherapeutics, Inc. $IOVAAugust 30, 2025 | marketbeat.comIovance Biotherapeutics to Present at Upcoming ConferencesAugust 29, 2025 | globenewswire.comIovance: Thin Margins, Dilution Threat Keep Risk SkewedAugust 27, 2025 | seekingalpha.comIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down - Here's WhyAugust 27, 2025 | marketbeat.comIovance Biotherapeutics, Inc. $IOVA Shares Sold by T. Rowe Price Investment Management Inc.August 27, 2025 | marketbeat.comCapital Fund Management S.A. Acquires 409,688 Shares of Iovance Biotherapeutics, Inc. $IOVAAugust 27, 2025 | marketbeat.comAlgert Global LLC Buys 224,482 Shares of Iovance Biotherapeutics, Inc. $IOVAAugust 26, 2025 | marketbeat.comIovance Biotherapeutics reports inducement grants under NASDAQ listing ruleAugust 26, 2025 | msn.comWhy Iovance Biotherapeutics Stock Got Mashed on MondayAugust 25, 2025 | fool.comArtisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational ChallengesAugust 25, 2025 | insidermonkey.comVanguard Group Inc. Purchases 243,438 Shares of Iovance Biotherapeutics, Inc. $IOVAAugust 25, 2025 | marketbeat.com1 Beaten-Down Stock That Could Soar By 261%, According to Wall StreetAugust 24, 2025 | fool.comDeutsche Bank AG Trims Holdings in Iovance Biotherapeutics, Inc. $IOVAAugust 23, 2025 | marketbeat.comIovance Biotherapeutics (IOVA) Receives Conditional Approval From Health CanadaAugust 22, 2025 | insidermonkey.comIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)August 22, 2025 | globenewswire.comIovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25August 21, 2025 | seekingalpha.comIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Up - Here's What HappenedAugust 21, 2025 | marketbeat.comIovance Biotherapeutics (NASDAQ:IOVA) Receives Buy Rating from HC WainwrightAugust 21, 2025 | marketbeat.comIovance Biotherapeutics (NASDAQ:IOVA) Trading Down 4.5% - Time to Sell?August 20, 2025 | marketbeat.comIovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced MelanomaAugust 20, 2025 | tmcnet.comIovance Biotherapeutics Gains Health Canada ApprovalAugust 20, 2025 | msn.comWhy Iovance Biotherapeutics Stock Was Climbing TodayAugust 19, 2025 | fool.comIovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’August 19, 2025 | msn.comIovance Biotherapeutics, Inc.: Iovance's Amtagvi (lifileucel) Receives Health Canada Approval for Advanced MelanomaAugust 19, 2025 | finanznachrichten.deIovance gets conditional Health Canada approval for AmtagviAugust 19, 2025 | msn.comIovance Biotherapeutics Shares Rise After Receiving Canadian Approval for Skin Cancer TreatmentAugust 19, 2025 | marketwatch.comIovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced MelanomaAugust 18, 2025 | globenewswire.comWells Fargo Lowers Iovance Biotherapeutics (IOVA) PT to $14 Despite Strong Amtagvi Sales, Q2 Revenue GrowthAugust 18, 2025 | finance.yahoo.comIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Recommendation of "Hold" from AnalystsAugust 16, 2025 | marketbeat.comIovance Biotherapeutics (IOVA) Projected 2025 Revenue Up To US$300 MillionAugust 14, 2025 | finance.yahoo.comIovance Biotherapeutics’ Earnings Call Highlights GrowthAugust 14, 2025 | theglobeandmail.comIovance Biotherapeutics (NASDAQ:IOVA) Trading Up 9.4% - Should You Buy?August 13, 2025 | marketbeat.comDelveInsight Business Research, LLP: Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsightAugust 12, 2025 | finanznachrichten.deIovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5% on Analyst DowngradeAugust 12, 2025 | marketbeat.comTruist Financial Keeps Their Hold Rating on Iovance Biotherapeutics (IOVA)August 10, 2025 | theglobeandmail.comIovance Biotherapeutics Second Quarter 2025 Earnings: Misses ExpectationsAugust 9, 2025 | finance.yahoo.comIovance Biotherapeutics (NASDAQ:IOVA) Given New $14.00 Price Target at Wells Fargo & CompanyAugust 9, 2025 | marketbeat.comIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down on Disappointing EarningsAugust 9, 2025 | marketbeat.comChardan Capital Lowers Iovance Biotherapeutics (NASDAQ:IOVA) Price Target to $20.00August 9, 2025 | marketbeat.com3 Stocks That Could Turn $1,000 Into $5,000 by 2030August 9, 2025 | fool.com Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IOVA Media Mentions By Week IOVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOVA News Sentiment▼1.140.84▲Average Medical News Sentiment IOVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOVA Articles This Week▼721▲IOVA Articles Average Week Get the Latest News and Ratings for IOVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Apellis Pharmaceuticals News Today Crinetics Pharmaceuticals News Today Kymera Therapeutics News Today Telix Pharmaceuticals News Today Amneal Pharmaceuticals News Today Ultragenyx Pharmaceutical News Today Scholar Rock News Today Xenon Pharmaceuticals News Today Viking Therapeutics News Today MorphoSys News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOVA) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOVA Stock Alerts